Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Maʻemaʻe >98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory

ʻO ka wehewehe pōkole:

Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate

CAS: 205448-66-4

Maʻemaʻe: >98.0% (HPLC)

ʻAno: ʻO ke keʻokeʻo a i ka pauda paʻa melemele

Kūwaena o Lenvatinib Mesylate CAS 857890-39-2

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate
Nā huaʻōlelo like Lenvatinib haumia 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D
Helu CAS 205448-66-4
Helu CAT RF-PI1970
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C12H10ClNO3
Kaumaha Molecular 251.67
Lae paila 377.4±37.0 ℃
ʻO ka mānoanoa 1.320±0.06 g/cm3
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Pau-keokeo a Melemele Paa Paa
1 H NMR Spectrum Kūlike me ka hoʻolālā
Maʻemaʻe / Kaʻina Hanana >98.0% (HPLC)
Nalo ma ka maloo <1.00%
Huina paumaele <2.00%
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Kūwaena/Hoʻomaemae o Lenvatinib Mesylate (CAS: 857890-39-2)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

1

FAQ:

Noi:

ʻO Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) kahi mea waena o Lenvatinib Mesylate (CAS: 857890-39-2).ʻO Lenvatinib kahi lāʻau maʻi maʻi thyroid i hoʻomohala ʻia e Eisai Corporation o Iapana (Code: E7080), nona ka mea paʻa o ka waha multi-receptor tyrosine kinase (RTK) a hiki ke kāohi i ka hana kinase o ka vascular endothelial growth factor Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Hiki nō hoʻi iā Lenvatinib ke kāohi i ke komo ʻana o nā RTK ʻē aʻe i ka angiogenesis pathological, ka ulu ʻana o ka maʻi maʻi, a me ka piʻi ʻana o ka maʻi maʻi koe wale nō kā lākou mau hana kelepona maʻamau me ka fibroblast growth factor (FGF) receptors FGFR1, 2, 3, a me 4;ʻO ka platelet-derived growth factor receptor (PDGFR [alpha]), KIT, a me RET.[Nā hōʻike]: He kūpono ʻo Lenvatinib no ka mālama ʻana i nā maʻi o ka maʻi maʻi thyroid o ka hoʻi hou ʻana a i ʻole ke ʻano metastasis, ke ʻano holomua a me ka radioactive iodine-refractory differentiated type.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou